MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 1 filers reported holding MAST THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $7,000 | +40.0% | 54,724 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -16.7% | 54,724 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | 0.0% | 54,724 | +317.0% | 0.00% | – |
Q2 2016 | $6,000 | +50.0% | 13,124 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | -33.3% | 13,124 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
Q3 2015 | $7,000 | +16.7% | 13,124 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | 0.0% | 13,124 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | -12.5% | 13,124 | -10.3% | 0.00% | – |
Q3 2014 | $8,000 | -11.1% | 14,624 | 0.0% | 0.00% | – |
Q2 2014 | $9,000 | -10.0% | 14,624 | 0.0% | 0.00% | – |
Q1 2014 | $10,000 | -33.3% | 14,624 | -50.0% | 0.00% | – |
Q4 2013 | $15,000 | +150.0% | 29,248 | +100.0% | 0.00% | – |
Q3 2013 | $6,000 | 0.0% | 14,624 | 0.0% | 0.00% | – |
Q2 2013 | $6,000 | – | 14,624 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,442,400 | $2,390,000 | 1.66% |
Ancora Advisors LLC | 1,848,045 | $811,000 | 0.14% |
SABBY MANAGEMENT, LLC | 3,639,571 | $1,598,000 | 0.10% |
Alyeska Investment Group, L.P. | 1,900,000 | $1,668,000 | 0.07% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,634,221 | $1,156,000 | 0.05% |
SHEPHERD KAPLAN KROCHUK, LLC | 602,776 | $265,000 | 0.04% |
PERKINS CAPITAL MANAGEMENT INC | 110,000 | $48,000 | 0.03% |
MILLENNIUM MANAGEMENT LLC | 2,900,000 | $1,273,000 | 0.00% |
FRANKLIN RESOURCES INC | 12,046,100 | $5,288,000 | 0.00% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 200,000 | $88,000,000 | 0.00% |